Spinal Disorders Causing Spasticity Requiring Tizanidine
Tizanidine is specifically indicated for spasticity caused by spinal cord injury and multiple sclerosis (a progressive neurological disease affecting the spinal cord), not for primary "spinal disorders" per se. 1
Primary Indications
The FDA-approved indications for tizanidine are clear and limited:
- Spinal cord injury - Direct traumatic or non-traumatic damage to the spinal cord 1
- Multiple sclerosis - A demyelinating disease that affects the spinal cord in 80-90% of patients, most commonly the cervical cord 2, 3
Tizanidine should be used specifically for chronic stroke patients when spasticity results in pain, poor skin hygiene, or decreased function 4. While stroke is not a spinal disorder, this represents an important guideline-supported use.
Clinical Context for Treatment
Tizanidine is considered when spasticity causes:
- Pain that impairs quality of life
- Poor skin hygiene from inability to position or clean affected limbs
- Decreased function interfering with activities of daily living or rehabilitation 4
Stepwise Approach
Before initiating tizanidine, guidelines recommend a hierarchical treatment strategy 4:
- First-line non-pharmacologic measures: Antispastic positioning, range of motion exercises, stretching, splinting, serial casting
- Oral medications (tizanidine, baclofen, dantrolene) when non-pharmacologic measures fail
- More invasive options: Botulinum toxin, intrathecal baclofen, neurosurgical procedures for refractory cases
Important Caveats
Tizanidine has been shown to improve spasticity and pain without loss of motor strength in chronic stroke patients 4, which distinguishes it from some alternatives. However, the evidence shows that while spasticity and pain may be reduced, no significant functional gains were consistently demonstrated 4.
The drug is not indicated for acute low back pain or musculoskeletal spasticity despite being studied in these conditions 5. The 2007 American College of Physicians guideline notes that while tizanidine has been studied for low back pain, there is little evidence for efficacy of baclofen or dantrolene (the other FDA-approved antispasticity drugs) in this context 5.
Common pitfall: Tizanidine is sometimes confused with general "muscle relaxants" for musculoskeletal pain, but its FDA approval is specifically for spasticity from upper motor neuron lesions (spinal cord injury, MS, stroke), not for muscle spasm from musculoskeletal conditions 1.